Technical and safety aspects of blood and marrow transplantation using G-CSF mobilized family donors

Transfusion Science

Volumn 17, Issue 4, 1996, Pages 611-618

  Kadar, Janos G ^a   Arseniev, Lubomir ^a   Schnitger, Karen ^a   Südmeier, Ingrid ^a   Zaki, Marlies ^a   Battmer, Karen ^a   Jacobs, Roland ^a   Diedrich, Helmut ^a   Poliwoda, Hubert ^a   Stangel, Walter ^a   Link, Hartmut ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APHERESIS; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CELL LOSS; CONFERENCE PAPER; CONTAMINATION; CRYOPRESERVATION; DONOR; FAMILY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; NORMAL HUMAN; SAFETY; SIBLING; STEM CELL; SUBCUTANEOUS DRUG ADMINISTRATION; T LYMPHOCYTE; THROMBOCYTE; THROMBOCYTE COUNT;

EID: 0347874851     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(96)90099-5     Document Type: Conference Paper

References (20)

1. Sheridan WP, Begley CG, Juttner CA, et al.: Effect of peripheral blood progenitor cell mobilised by filgastrim (G-CSF) on platelet recovery after high dose chemotherapy. Lancet 1992; 339:640-643.
2. Russel NH, Pacey S: Economic evaluation of peripheral blood stem cell transplantation for lymphoma. Lancet 1992; 340:1280-1282.
3. Russel NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 1993; 341:1482-1484.
4. Arseniev L, Tischler MJ, Battmer K, Sudmeier I, Casper J, Link H: Treatment of poor marrow function with allogeneic CD 34+ cells immunoselected from G-CSF mobilised peripheral blood progenitor cells of the marrow donor. Bone Marrow Transplant 1994; 14:147-797.
5. Link H, Arseniev L, Bahre O, et al.: Combined transplantation of allogeneic bone marrow and CD34+ blood cells. Blood 1995, 86:2500-2508.
6. Link H, Arseniev L, Bahre O, Kadar JG, Diedrich H, Poliwoda H: Transplantation of allogeneic CD34+ blood cells. Blood 1996; 87:4903-4909.
7. Arseniev L, Goudeva L, Kadar JG, et al.: Flow cytometry quantification of CD34+ cells other leukocyte subpopulations in frozen thawed blood cell suspensions: Investigation of a new Teflon container for cryopreservation of hematopoietic progenitor cells. Infusionsther Transfusionsmed 1995; 22:152-158.
8. Klein HG: Standards for Blood Banks and Transfusion Services, 16th ed. Arlington, AABB, 1994.
9. Avenarius HJ, Freund M, Kleine HD, Heußner P, Poliwoda H: Granulocyte colony stimulating factor enhances the expression of CD62 on platelets in vivo. Int J Hematol 1993; 56:189-196.
10. dim) lymphoid subsets possible predictors of engraftment graft versus host disease. Blood 1995; 86:2842-2848.
11. Roberts AW, DeLuca EM, Begley CG, Basser R, Grigg AP, Metcalf D: Broad interindividual variations in circulating progenitor cell numbers induced by granulocyte colony stimulating factor therapy. Stem Cells 1995; 13:512-516.
12. Bonilla MA, Dale D, Zeidler C, et al.: Long term safety of treatment with recombinant human granulocyte colony stimulating factor (R-metHuG-SCF) in patients with severe congenital neutropenia. Br J Haematol 1994; 88:723-730.
13. Welte K, Dale DC: Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996; 72:158-165.
14. Rock G, Tittley P, Sternbach M, Buskard N, Schroeder M: Repeat plateletpheresis: The effects on the donor and the yield. Vox Sang 1992; 63:102-106.
15. Strauss RG: Effect on donors of repeated leukocyte losses during plateletpheresis. J Clin Apheresis 1994; 9:130-134.
16. Borberg H: Cellular substitution, in Gross R, Schmidt CG (eds): Clinical Oncology. Stuttgart, New York, Georg Thieme, 1985, pp. 20.20-20.28
17. Sarles HE, Remmers AR, Beathard GA, et al.: Suppression of cellular immunity by lymph duct drainage in man. Clin Res 1968; 176:3223-3226.
18. Körbling M, Przepiorka D, Huh YO, et al.: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: Potential advantages of blood over marrow allografts. Blood 1995; 85:1655-1658.
19. Bensinger WI, Weaver CH, Appelbaum F, et al.: Transplantation of allogeneic peripheral blood stem cells mobilised by recombinant human granulocyte colony stimulating factor. Blood 1995; 85:1659-1662.
20. McCullough J: The new generation of blood components. Transfusion 1995; 35:374-376.